IndraLab

Statements



reach
"71 N-palmitoylethanolamine, a cannabinoid receptor CB2 agonist, has been compounded into creams and shown to reduce pruritus within days in patients with AD, lichen simplex chronicus, prurigo nodularis, and uremic pruritus."

reach
"Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis."